CClinicalTrials.gg
Status unknownNCT04128592NiNbIUpdated Oct 16, 2019

Non-invasive Differential Diagnosis of Noisy Breathing Infants and Toddlers

An interventional study of diagnosing noisy breathing in infants and toddlers in Noisy Breathing Infants, Noist Breathing Toddlers and Wheezing, sponsored by Hasselt University. Status unknown at 1 site in Belgium. Open to participants aged 2 Months to 18 Months. Per ClinicalTrials.gov, last updated 2019-10-16.

Sponsored by Hasselt University · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Oct 2019), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Oct 2018, registered Aug 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Non-randomized
Ages
2 Months to 18 Months
Sex
All
01

Study summary

Almost 50% of all children have at least 1 episode of noisy breathing before the age of 2 years and almost 25% of these children have more episodes of noisy breathing. The lack of an objective technique for diagnosing noisy breathing children often leads to overrated diagnosis of "wheezing", whereas there may be other noisy breathing phenotypes, like "rattling", that don't favor from the same therapeutic treatment. Presumably, different underlying pathophysiological mechanisms are involved with different biomarker profiles characteristic for different phenotypes. The goal of this study is to optimize the diagnosis of noisy breathing infants and toddlers. Children will be followed for a treatment period of 6 weeks and will visit the paediatrician 3 times (week 0, 3 and 6). During the consultations breath sound analysis will be performed and a breath sample and a nasal mucus will be collected to analyse biomarker profiles. Both methods for diagnosing noisy breathing infants are non-invasive and will be compared to the standard procedure of the paediatrician which consists of auscultation and palpation of the chest. An objective and non-invasive method for diagnosing noisy breathing infants and toddler will pave the way for more cost-effective and personalized prescription of therapies which will increase the quality of life of children with noisy breathing.

02

Conditions studied

  • Noisy Breathing Infants
  • Noist Breathing Toddlers
  • Wheezing
  • Rattling
03

In context

Respiratory Aspiration

1,092 studies on the registry are indexed under Respiratory Aspiration; 216 are open to participants now.

This study's planned enrollment of 100 is above the median of 42 across 881 interventional studies indexed under Respiratory Aspiration.

Browse Respiratory Aspiration studies →

Lead sponsor

Hasselt University is the lead sponsor of 195 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Months to 18 Months
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • clinical diagnosis of noisy breathing ("wheezing" or "rattling")

Exclusion criteria

Exclusion Criteria:

  • born before pregnancy week 37
  • congenital or genetic conditions (Down syndrome, Klinefelter's syndrome, ...)
  • acquired chronic respiratory diseases (bronchopulmonary dysplasy, lung fibrosis, ...)
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Other
    Wheezing

    Device: diagnosing noisy breathing in infants and toddlers

  • Other
    Rattling

    Device: diagnosing noisy breathing in infants and toddlers

Interventions

  • Devicediagnosing noisy breathing in infants and toddlers

    breath sampling and nasal mucus sampling to analyze biomarkers and breath sound analysis to diagnose noisy breathing.

06

What researchers measure

Primary outcomes

  1. Noisy breathing diagnosis made by pediatrician based on anamnesis and auscultation

    Noisy breathing diagnosis is made by the same pediatrician and is based on intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or of continuous duration.

    Time frame: week 0

  2. Noisy breathing diagnosis made by pediatrician based on anamnesis and auscultation

    Noisy breathing diagnosis is made by the same pediatrician and is based on intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or of continuous duration.which differentiate "wheezing" and "rattling" infants and toddlers. Comparing diagnosis based on these biomarker profiles to the diagnosis made by the pediatrician based on auscultation and palpation.

    Time frame: week 3

  3. Noisy breathing diagnosis made by pediatrician based on anamnesis and auscultation

    Noisy breathing diagnosis is made by the same pediatrician and is based on intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or of continuous duration.which differentiate "wheezing" and "rattling" infants and toddlers. Comparing diagnosis based on these biomarker profiles to the diagnosis made by the pediatrician based on auscultation and palpation.

    Time frame: Week 6

  4. exhaled breath volatiles

    exhaled breath volatiles analyzed with Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) and Gas Chromatography Mass Spectrometry (GC-MS)

    Time frame: week 0

  5. exhaled breath volatiles

    exhaled breath volatiles analyzed with Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) and Gas Chromatography Mass Spectrometry (GC-MS)

    Time frame: week 3

  6. exhaled breath volatiles

    exhaled breath volatiles analyzed with Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) and Gas Chromatography Mass Spectrometry (GC-MS)

    Time frame: week 6

  7. respiratory pathogens

    respiratory pathogens present in a nasopharyngeal swab detected using PCR

    Time frame: week 0

  8. respiratory pathogens

    respiratory pathogens present in a nasopharyngeal swab detected using PCR

    Time frame: week 3

  9. respiratory pathogens

    respiratory pathogens present in a nasopharyngeal swab detected using PCR

    Time frame: week 6

  10. level of inflammation markers

    level of inflammation markers in the nasopharyngeal swab using multiplex immune-assay

    Time frame: week 0

  11. level of inflammation markers

    level of inflammation markers in the nasopharyngeal swab using multiplex immune-assay

    Time frame: week 3

  12. level of inflammation markers

    level of inflammation markers in the nasopharyngeal swab using multiplex immune-assay

    Time frame: week 6

Secondary outcomes

  1. Breath sound recordings evaluated by expert panel of pediatricians

    Intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or continuous over the recording.

    Time frame: week 0

  2. Breath sound recordings evaluated by expert panel of pediatricians

    Intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or continuous over the recording.

    Time frame: week 3

  3. Breath sound recordings evaluated by expert panel of pediatricians

    Intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or continuous over the recording.

    Time frame: week 6

  4. Treatment response assessed by online journal for parents

    Parents are asked what type of noisy breathing symptoms their child had during the day. Options are: (1) Wheezing; (2) Rattling; (3) Both, but mostly wheezing; (4) Both, but mostly rattling; (5) Both in equal amounts, (6) No noisy breathing today. In the online questionnaire sound fragments of wheezing and rattling are available incase parents are in doubt.

    Time frame: week 6

  5. Recurrence of symptoms assessed by follow up questionnaire

    Online questionnaire asks about noisy breathing symptoms in the past 3 months, their frequency and seriousness. In the online

    Time frame: 3 months after week 6

  6. Recurrence of symptoms assessed by follow up questionnaire

    Online questionnaire asks about noisy breathing symptoms in the past 3 months, their frequency and seriousness. In the online

    Time frame: 6 months after week 6

  7. Recurrence of symptoms assessed by follow up questionnaire

    Online questionnaire asks about noisy breathing symptoms in the past 3 months, their frequency and seriousness. In the online

    Time frame: 9 months after week 6

  8. Recurrence of symptoms assessed by follow up questionnaire

    Online questionnaire asks about noisy breathing symptoms in the past 3 months, their frequency and seriousness. In the online

    Time frame: 12 months after week 6

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 16, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04128592
Lead sponsor
Hasselt University
Collaborators
Jessa Hospital, VITO
Responsible party
Marc Raes (prof. dr., Hasselt University) — Principal investigator
First posted
Oct 16, 2019
Start date
Oct 30, 2018
Primary completion
Mar 2020 (estimated)
Completion
May 2020 (estimated)
Last update
Oct 16, 2019

Study contacts

Marc Raes, prof. dr.
Contact
marc.raes@jessazh.be
+32 11 30 84 65
Gitte Slingers, drs.
Contact
gitte.slingers@uhasselt.be
+32 11 30 84 65
Marc Raes, prof. dr.
principal investigator · Jessa Hospital
Gitte Slingers, drs.
study chair · Hasselt University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion